Medical devices, healthcare technology and the business of care
PMA approval · P990004

SURGIFOAM ABSORBABLE GELATIN SPONGE, USP

Ferrosan Meidcal Devices A/S · Decision date Sep 30, 1999

MEDTECHLEDGER EXPLANATIONP990004

What did the FDA approve?

FDA approved PMA P990004 for SURGIFOAM Absorbable Gelatin Sponge, U.S.P. on September 30, 1999. The approval statement describes the device as indicated for hemostasis in surgical procedures, excluding urologic, ophthalmic, and neurologic procedures, when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures is ineffective or impractical.

The applicant is Ferrosan Medical Devices A/S, and the device is categorized as an absorbable hemostatic agent, collagen based, under product code LMF. The record does not identify a supplement type or reason, so no change to an earlier PMA can be described from these fields. The statement reports the device's intended purpose as stated in the approval; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

Approval for the SURGIFOAM Absorbable Gelatin Sponge, U.S.P. This device is indicated for surgical procedures (except urologic, ophthalmic and neurologic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical.
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Sep 30, 1999

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P990004
Regulatory pathway
Premarket approval application
Product code
LMF
Decision code
APPR
Decision date
Sep 30, 1999
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, absorbable hemostatic, collagen based.

Product code
LMF
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P990004 received

    Application receipt date recorded by FDA.

  2. P990004 · FDA decision

    APPR

  3. P990004/S080 · Related supplement

    SURGIFOAM Absorbable Gelatin Sponge

Timeline entries are records held by MedtechLedger for P990004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990004

Product / regulatory recordCompanyPathwayDecision dateSource
Ferrosan Meidcal Devices A/SPMA supplementSep 18, 2026FDA

Explore the linked device profile

Other records with product code LMF

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ferrosan Meidcal Devices A/S

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sydmarken 5, Soeborg, 08876

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records